Antibiotics are fundamental to modern medicine, essential for treating everything from routine skin infections to strep throat, and for protecting vulnerable patients receiving chemotherapy or being treated in intensive care units.
Although antibiotic resistance is not a new problem, its scope now constitutes a major threat to human health. According to the Centers for Disease Control and Prevention, at least 2 million Americans fall sick every year with antibiotic-resistant infections—and 23,000 die.
Medical and public health experts agree that addressing antibiotic resistance requires measures that will ensure both the prudent use of existing drugs and a robust pipeline of new drugs. Pew's antibiotic resistance project supports policies that would:
- Spur the creation of new antibiotics by removing the regulatory, economic, and scientific obstacles that impede antibiotic discovery and development.
- Establish stewardship programs to ensure that antibiotics are prescribed only when necessary in human health care settings.
- End the overuse of antibiotics in food animals.
Analysis shows more than 1 in 3 labels will not fully meet judicious use standards after implementation of FDA policy
New data needed to improve prescribing, combat threat of antibiotic resistance
At the 70th World Health Assembly (WHA), held in Geneva from May 22 to 31, antimicrobial resistance (AMR) remained high on the agenda. Building on commitments from world leaders at last year’s United Nations General Assembly meeting, the WHA brought together stakeholders from around the world—including government officials, nongovernmental organizations, public health experts, and... Read More
The fiscal year 2018 budget blueprint released by the Trump administration proposes cuts that, if adopted by Congress, would undermine efforts critical to protecting the health of Americans. Pew works on a number of public health issues that could be affected. Read More
Nontraditional products are unlikely to fully substitute or replace antibiotic use but could provide new treatment options for patients through combined use with antibiotics or as a means of preventing an infection from taking hold. Questions remain regarding how nontraditional products should be tested for safety and efficacy, and how they could be used appropriately in the clinical setting. Read More